{
  "symbol": "GE",
  "year": 2025,
  "Period": "Q1",
  "report_type": "Q10",
  "metrics": {
    "mdna_sentiment": -0.3182,
    "outlook_sentiment": 0.2775,
    "forward_ratio": 1.0,
    "hedge_ratio": 0.08
  },
  "top_positive": [
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Principal pension plans (benefit) cost (Note 13) ( 324 ) ( 328 ) Principal pension plans employer contributions ( 95 ) ( 94 ) Other postretirement benefit plans (net) ( 133 ) ( 155 ) Provision (benefit) for income taxes (Note 15) 671 369 Cash recovered (paid) during the year for income taxes ( 253 ) 91 Changes in operating working capital: Decrease (increase) in current receivables ( 1,157 ) ( 48 ) Decrease (increase) in inventories, including deferred inventory costs ( 1,394 ) ( 1,201 ) Decrease (increase) in current contract assets ( 65 ) 155 Increase (decrease) in contract liabilities and current deferred income 384 386 Increase (decrease) in progress collections 269 290 Increase (decrease) in accounts payable 1,495 427 Increase (decrease) in sales discounts and allowances 447 ( 102 ) All other operating activities ( 417 ) ( 528 ) Cash from (used for) operating activities \u2013 continuing operations 3,891 2,586 Cash from (used for) operating activities \u2013 discontinued oper\nerformance metric at the company level for our performance stock units granted in 2025.",
      "score": 0.9972
    },
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Principal pension plans (benefit) cost (Note 13) ( 324 ) ( 328 ) Principal pension plans employer contributions ( 95 ) ( 94 ) Other postretirement benefit plans (net) ( 133 ) ( 155 ) Provision (benefit) for income taxes (Note 15) 671 369 Cash recovered (paid) during the year for income taxes ( 253 ) 91 Changes in operating working capital: Decrease (increase) in current receivables ( 1,157 ) ( 48 ) Decrease (increase) in inventories, including deferred inventory costs ( 1,394 ) ( 1,201 ) Decrease (increase) in current contract assets ( 65 ) 155 Increase (decrease) in contract liabilities and current deferred income 384 386 Increase (decrease) in progress collections 269 290 Increase (decrease) in accounts payable 1,495 427 Increase (decrease) in sales discounts and allowances 447 ( 102 ) All other operating activities ( 417 ) ( 528 ) Cash from (used for) operating activities \u2013 continuing operations 3,891 2,586 Cash from (used for) operating activities \u2013 discontinued operations ( 136 ) ( 681 ) Cash from (used for) operating activities 3,755 1,905 Additions to property, plant and equipment and internal-use software ( 535 ) ( 499 ) Dispositions of property, plant and equipment 25 87 Proceeds from principal business dispositions \u2014 74 Net cash f\n $ 21,876 million, of which $ 13,707 million and $ 14,011 million had gross unrealized losses of $( 2,652 ) million and $( 2,795 ) million and have been in a loss position for 12 months or more at June 30, 2025 and December 31, 2024, respectively.",
      "score": 0.9967
    },
    {
      "sent": "Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Princi\npany and increased period-to-period comparability, as well as a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding items that are not closely related with ongoing operations.",
      "score": 0.9962
    }
  ],
  "top_negative": [
    {
      "sent": "and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S.",
      "score": -0.9674
    },
    {
      "sent": "and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S.",
      "score": -0.9674
    },
    {
      "sent": "and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S.",
      "score": -0.9674
    }
  ],
  "forward_snippets": [
    "We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates.",
    "We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts.",
    "We are in frequent communication with our airline, airframe and maintenance, repair and overhaul (MRO) customers about the outlook for commercial air travel, new aircraft production, fleet retirements and after-market services, including shop visit and spare parts demand.",
    "We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates.",
    "We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts."
  ],
  "curated_text": "Symbol: GE. Year: 2025. Period: Q1. ReportType: Q10. Section: Management Discussion and Analysis (MD&A). Key metrics include sentiment, forward outlook, and risk hedging.  Top positive sentences: Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Principal pension plans (benefit) cost (Note 13) ( 324 ) ( 328 ) Principal pension plans employer contributions ( 95 ) ( 94 ) Other postretirement benefit plans (net) ( 133 ) ( 155 ) Provision (benefit) for income taxes (Note 15) 671 369 Cash recovered (paid) during the year for income taxes ( 253 ) 91 Changes in operating working capital: Decrease (increase) in current receivables ( 1,157 ) ( 48 ) Decrease (increase) in inventories, including deferred inventory costs ( 1,394 ) ( 1,201 ) Decrease (increase) in current contract assets ( 65 ) 155 Increase (decrease) in contract liabilities and current deferred income 384 386 Increase (decrease) in progress collections 269 290 Increase (decrease) in accounts payable 1,495 427 Increase (decrease) in sales discounts and allowances 447 ( 102 ) All other operating activities ( 417 ) ( 528 ) Cash from (used for) operating activities \u2013 continuing operations 3,891 2,586 Cash from (used for) operating activities \u2013 discontinued oper\nerformance metric at the company level for our performance stock units granted in 2025. Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Principal pension plans (benefit) cost (Note 13) ( 324 ) ( 328 ) Principal pension plans employer contributions ( 95 ) ( 94 ) Other postretirement benefit plans (net) ( 133 ) ( 155 ) Provision (benefit) for income taxes (Note 15) 671 369 Cash recovered (paid) during the year for income taxes ( 253 ) 91 Changes in operating working capital: Decrease (increase) in current receivables ( 1,157 ) ( 48 ) Decrease (increase) in inventories, including deferred inventory costs ( 1,394 ) ( 1,201 ) Decrease (increase) in current contract assets ( 65 ) 155 Increase (decrease) in contract liabilities and current deferred income 384 386 Increase (decrease) in progress collections 269 290 Increase (decrease) in accounts payable 1,495 427 Increase (decrease) in sales discounts and allowances 447 ( 102 ) All other operating activities ( 417 ) ( 528 ) Cash from (used for) operating activities \u2013 continuing operations 3,891 2,586 Cash from (used for) operating activities \u2013 discontinued operations ( 136 ) ( 681 ) Cash from (used for) operating activities 3,755 1,905 Additions to property, plant and equipment and internal-use software ( 535 ) ( 499 ) Dispositions of property, plant and equipment 25 87 Proceeds from principal business dispositions \u2014 74 Net cash f\n $ 21,876 million, of which $ 13,707 million and $ 14,011 million had gross unrealized losses of $( 2,652 ) million and $( 2,795 ) million and have been in a loss position for 12 months or more at June 30, 2025 and December 31, 2024, respectively. Period Total number of shares purchased Average price paid per share Total number of shares purchased as part of our share repurchase authorizations Approximate dollar value of shares that may yet be purchased under our $15 billion  share repurchase authorization (Shares in thousands) 2025 April 1,456 $ 181.33 1,456 May 6,062 229.06 5,687 June \u2014 \u2014 \u2014 Total 7,518 $ 219.81 7,143 $ 6,544 *Non-GAAP Financial Measure 14 2025 2Q FORM 10-Q STATEMENT OF OPERATIONS (UNAUDITED) Three Months Ended June 30 Six months ended June 30 (In millions; per-share amounts in dollars) 2025 2024 2025 2024 Sales of equipment $ 2,842 $ 2,175 $ 5,496 $ 4,596 Sales of services 7,308 6,047 13,656 11,702 Insurance revenue (Note 12) 872 871 1,806 1,750 Total revenue 11,023 9,094 20,957 18,048 Cost of equipment sold 2,754 2,302 5,090 4,767 Cost of services sold 4,092 3,273 7,753 6,554 Selling, general and administrative expenses 1,020 924 1,896 1,950 Separation costs 47 75 98 334 Research and development 359 300 718 570 Interest and other financial charges 158 248 368 511 Insurance losses, annuity benefits and other costs (Note 12) 698 667 1,400 1,293 Non-operating benefit cost (income) ( 197 ) ( 204 ) ( 398 ) ( 421 ) Total costs and expenses 8,932 7,584 16,924 15,558 Other income (loss) (Note 18) 298 ( 63 ) 600 944 Net income (loss) from continuing operations before income taxes 2,389 1,447 4,634 3,434 Benefit (provision) for income taxes (Note 15) ( 388 ) ( 125 ) ( 671 ) ( 369 ) Net income (loss) from continuing operations 2,000 1,322 3,962 3,065 Net income (loss) from discontinued operations, net of taxes (Note 2) 21 ( 54 ) 31 ( 232 ) Net income (loss) 2,021 1,268 3,993 2,833 Less net income (loss) attributable to noncontrolling interests ( 7 ) 2 ( 13 ) 28 Net income (loss) attributable to the Company 2,028 1,266 4,006 2,805 Net income (loss) attributable to common shareholders $ 2,028 $ 1,266 $ 4,006 $ 2,805 Earnings (loss) per share from continuing operations (Note 17) Diluted earnings (loss) per share $ 1.87 $ 1.20 $ 3.70 $ 2.78 Basic earnings (loss) per share $ 1.89 $ 1.21 $ 3.73 $ 2.81 Net earnings (loss) per share (Note 17) Diluted earnings (loss) per share $ 1.89 $ 1.15 $ 3.73 $ 2.55 Basic earnings (loss) per share $ 1.91 $ 1.16 $ 3.76 $ 2.58 2025 2Q FORM 10-Q 15 STATEMENT OF FINANCIAL POSITION (UNAUDITED) (In millions, except share amounts) June 30, 2025 December 31, 2024 Cash, cash equivalents and restricted cash $ 10,861 $ 13,619 Investment securities (Note 3) 998 982 Current receivables (Note 4) 10,512 9,327 Inventories, including deferred inventory costs (Note 5) 11,297 9,763 Current contract assets (Note 8) 3,059 2,982 All other current assets (Note 9) 1,073 962 Current assets 37,801 37,635 Investment securities (Note 3) 37,887 37,741 Property, plant and equipment \u2013 net (Note 6) 7,523 7,277 Goodwill (Note 7) 9,006 8,538 Other intangible assets \u2013 net (Note 7) 4,336 4,257 Contract and other deferred assets (Note 8) 4,803 4,831 All other assets (Note 9) 15,002 13,910 Deferred income taxes (Note 15) 6,890 7,111 Assets of discontinued operations (Note 2) 2,007 1,841 Total assets $ 125,256 $ 123,140 Short-term borrowings (Note 10) $ 1,889 $ 2,039 Accounts payable (Note 11) 9,495 7,909 Progress collections (Note 8) 7,026 6,695 Contract liabilities and deferred income (Note 8) 9,738 9,353 Sales discounts and allowances (Note 14) 3,923 3,475 All other current liabilities (Note 14) 4,395 4,920 Current liabilities 36,466 34,392 Deferred income (Note 8) 1,040 1,013 Long-term borrowings (Note 10) 16,998 17,234 Insurance liabilities and annuity benefits (Note 12) 36,745 36,209 Non-current compensation and benefits 6,796 7,035 All other liabilities (Note 14) 6,504 6,376 Liabilities of discontinued operations (Note 2) 1,362 1,317 Total liabilities 105,911 103,576 Common stock ( 1,060,439,387 and 1,073,692,183 shares outstanding at June 30, 2025 and December 31, 2024, respectively)  (Note 16) 15 15 Accumulated other comprehensive income (loss) \u2013 net attributable to the Company (Note 16) ( 4,024 ) ( 3,861 ) Other capital 23,839 24,266 Retained earnings 83,726 80,488 Less common stock held in treasury ( 84,421 ) ( 81,566 ) Total shareholders\u2019 equity 19,135 19,342 Noncontrolling interests 210 223 Total equity 19,345 19,564 Total liabilities and equity $ 125,256 $ 123,140 16 2025 2Q FORM 10-Q STATEMENT OF CASH FLOWS (UNAUDITED) Six months ended June 30 (In millions) 2025 2024 Net income (loss) $ 3,993 $ 2,833 Net (income) loss from discontinued operations activities ( 31 ) 232 Adjustments to reconcile net income (loss) to cash from (used for) operating activities: Depreciation and amortization of property, plant and equipment 428 401 Amortization of intangible assets (Note 7) 182 172 (Gains) losses on equity securities (Note 18) ( 109 ) ( 314 ) Princi\npany and increased period-to-period comparability, as well as a more complete understanding of underlying operating results and trends of established, ongoing operations by excluding items that are not closely related with ongoing operations. Top negative sentences: and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S. and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S. and other countries (including implementation of new tariffs and retaliatory measures); demand or supply shocks from events such as a major terrorist attack, war (including the ongoing conflict between Russia and Ukraine and conflict in the Middle East), natural disasters or actual or threatened public health pandemics or other emergencies; \u2022 market or other developments that may affect demand or the financial strength and performance of airframers, airlines, suppliers and other key aerospace and defense industry participants, such as demand for air travel, supply chain or other production constraints, shifts in U.S. Forward-looking snippets: We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates. We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts. We are in frequent communication with our airline, airframe and maintenance, repair and overhaul (MRO) customers about the outlook for commercial air travel, new aircraft production, fleet retirements and after-market services, including shop visit and spare parts demand. We continue to partner with our suppliers to improve material input, and work with our customers to calibrate future production rates. We expect the impact of supply chain constraints and inflation will continue, and we are continuing to take action to mitigate the impacts."
}